Articles tagged with Embryonic Stem Cells
A team of scientists from the University of Wisconsin-Madison has developed methods for recombining DNA segments in human embryonic stem cells using homologous recombination. This technique allows for manipulating any part of the human genome to study gene function and mimic human diseases.
Dr. Rossant and colleagues find that Flk1 and Tal1 proteins steer embryonic cells towards endothelial, hematopoietic, or smooth muscle fates. The study provides further evidence for a common hemangioblast progenitor cell, which can differentiate into the three cell types.
Researchers discovered that Sox2 is a crucial transcription factor involved in the specification of three embryonic cell lineages. The study found that Sox2-deficient embryos exhibit fatal defects, highlighting its importance in maintaining cellular pluripotency and embryo formation.
Researchers successfully transplanted myoblast cells into patients with scarred heart tissue, showing evidence of repair and regeneration. The procedure improved EF rates by 58% in just 12 weeks, offering a potential new hope for treating heart failure.
Researchers discovered Foxd3 as a crucial gene regulating embryonic stem cell fate and pluripotency. The gene is required for normal embryonic development, including the formation of inner cell mass and extraembryonic tissues.
A study published by University of Pennsylvania School of Medicine reveals the Foxd3 gene plays a vital role in maintaining stem cells' pluripotency. The findings suggest that Foxd3 is essential for embryonic development and has diagnostic significance for human embryonic stem cells.
Researchers at Princeton University identified a core set of genes responsible for regulating stem cell behavior and unique activities. The study also uncovered over 4,000 genes active in surrounding tissues that influence stem cell behavior.
Researchers identified 216 'stemness' genes that are active in embryonic, neural, and hematopoietic stem cells. These genes are involved in coping with stress, signaling, and self-renewal, and can aid in developing techniques to induce stem cells to differentiate into specific adult cells.
A Stanford study found that a single adult stem cell could only repopulate blood and immune cells in mice, casting doubt on its ability to form all adult tissues. The research suggests that embryonic stem cells remain the most promising option for tissue formation.
Researchers at Vanderbilt University Medical Center have discovered a gene, PTF1p48, that plays a crucial role in the development of the pancreas. The study found that p48 is required for the formation of both exocrine and endocrine cells, which could lead to the production of insulin-secreting cells from embryonic or other stem cells.
Adult stem cells have intrinsic properties and respond differently to environmental signals, suggesting a new approach to repairing damaged PNS tissue without transplanting exogenous cells. The study reveals that matching the origin of the stem cell to the specific tissue being repaired is crucial for successful application.
Researchers have discovered stem cells in the adult peripheral nervous system, which can persist into adulthood and give rise to thousands of neurons, glial cells, and smooth muscle cells. This finding has significant implications for understanding the development and repair of the peripheral nervous system.
Scientists have made a breakthrough in growing functioning motor neurons from embryonic stem cells, a crucial step towards regenerating nerve tissue lost to disease or trauma. The success of the experiments suggests that human motor neurons can be grown using the same approach.
Researchers created four new mouse embryonic germ cell lines to investigate imprinting and its control. They found that the mother's copy of a paternally imprinted gene was active instead of the expected father's copy.
Researchers found that human embryonic germ cells and their specialized daughter cells maintain correct 'imprinting,' a way cells determine gene expression. This is critical information for the safe clinical use of these cells in treating diseases.
Researchers have successfully transplanted embryonic stem cell-derived neurons into a rat model for Parkinson's disease, reducing disease symptoms and establishing functional connections. This breakthrough finding suggests that embryonic stem cells may be useful for treating PD and other brain diseases.
Researchers at the University of Minnesota have found evidence that adult bone marrow-derived cells can differentiate into cells of all three embryonic germ layers, similar to embryonic stem cells. These multipotent adult progenitor cells (MAPCs) show potential for treating genetic and degenerative disorders without tumor formation.
Researchers at Boston Children's Hospital used therapeutic cloning to create functional tissue in cows, including heart, muscle, and kidney tissue. The cloned cells showed no rejection response, a promising development for treating diseases with stem cells.
A new bioreactor-based technique has improved stem cell cultivation, allowing for large-scale production and higher efficiency. This breakthrough could lead to significant advancements in regenerative medicine and tissue engineering.
Researchers analyzed cloned mouse embryos for Oct4 gene expression to evaluate genetic reprogramming. Most cumulus-cloned embryos failed to properly reprogram their Oct4 gene pattern, resulting in low developmental potential and viability.
Researchers at Rush University Medical Center have identified the signal that instructs stem/progenitor cells to become dopamine neurons, a key step in treating Parkinson's disease. By cloning and transplanting these specific cells, the team hopes to develop new treatments for Parkinson's, Alzheimer's, and other diseases.
The NIH has granted $3.5 million in funding to four institutions to enhance their human embryonic stem cell (hESC) research infrastructure. The funds will support the expansion, testing, quality assurance, and distribution of existing cell lines, enabling basic scientists to access these cells for research.
Researchers successfully combined therapeutic cloning, embryonic stem cell differentiation, and gene therapy to treat a genetic immune disorder in mice. The study demonstrates the potential for nuclear transplantation therapy to correct genetic mutations and restore function in human patients.
Researchers from the Whitehead Institute for Biomedical Research have successfully cloned mouse embryos from mature B and T cell nuclei, demonstrating that fully differentiated adult cells can form clones. However, the process is extremely inefficient, and it is more likely that elusive adult stem cells are responsible for cloning.
Scientists have successfully generated primate stem cells from an unfertilized embryo through parthenogenesis, demonstrating the ability to produce various cell types, including midbrain dopamine neurons. This breakthrough could lead to new treatments for diseases such as Parkinson's and Huntington's, heart disease, and diabetes.
Researchers found that embryonic stem cells can survive in damaged heart muscle and improve cardiac function. The study demonstrated significant reduction of MI damage and improvement in left ventricular function, suggesting a potential future treatment option for congestive heart failure.
Researchers have identified a molecule, GCNF, that restricts mouse cells' potency. This discovery may allow for the creation of embryonic stem cells without sacrificing embryos, opening up new avenues for research.
A team of scientists has successfully guided human embryonic stem cells to become precursor brain cells in a laboratory dish. Transplanted into baby mice, these cells further differentiated into neurons and astrocytes, paving the way for potential treatments of Parkinson's disease and spinal cord injuries.
Researchers at University of Wisconsin-Madison successfully directed undifferentiated human embryonic stem cells to become primitive types of blood cells, which later develop into mature blood cells. This breakthrough technology holds promise for creating novel sources of blood cells for transfusion and transplant therapies.
QSulf1 enables embryonic cells to express muscle-specific proteins by modifying signaling co-factors. This discovery sheds light on the complex process of cell differentiation and has implications for regenerative medicine.
A new enzyme increases the number and size of heart muscle cells in mice, allowing them to live longer. This discovery could lead to gene-based therapies for heart disease, with potential benefits for millions of Americans affected by the condition.
John D. Gearhart praises the policy as a good starting point for expanding stem cell research, despite limitations in funding and oversight. He emphasizes the potential of federal funding to accelerate progress and improve human health through advances in understanding and treating various diseases.
The use of embryonic stem cells is a contentious issue, with proponents arguing that they hold promise for medical breakthroughs. However, opponents claim that destroying an embryo is tantamount to infanticide. Scientists generally favor the use of embryonic stem cells due to their versatility.
Gene expression is found to be highly variable in cloned mice, with imprinted genes showing widespread aberrant regulation. This variability may contribute to the large offspring and respiratory problems commonly seen in clones.
Scientists discovered that even seemingly normal-looking clones may have subtle aberrations in gene expression, which can affect development. The study found that mouse clones made from embryonic stem cells exhibited irregular gene expression, highlighting the potential risks of reproductive cloning.
Researchers have identified regulatory cells that govern the behavior of stem cells in Drosophila, revealing a specialized cellular environment known as a niche. The niche environment provides support needed for stem cell self-renewal, and its characteristics may offer insights into human stem cell regulation.
Researchers at BresaGen are working on developing cell-based therapies for Parkinson's Disease and genetic diseases using human embryonic stem cells. The company is focusing on deriving stem cells from normal adult cells to overcome ethical concerns.
Researchers have discovered retinal stem cells in adult mice, cows, and humans, which can proliferate and differentiate into new neurons when removed from the eye. The study suggests that these cells may be harnessed to regenerate and restore vision in damaged eyes.
The AAAS study recommends using federal funding for research on human stem cells, including embryonic stem cells already isolated in laboratories. However, the derivation of human stem cells should not receive federal funding due to public anxiety surrounding its process.
Scientists at University of Wisconsin-Madison successfully derive human embryonic stem cells (hES cells), which can form all cell types and tissues, holding great promise for transplantation medicine and drug discovery. The availability of hES cells opens extraordinary opportunities for tissue transplantation and cell and gene therapy ...
Researchers at University of Wisconsin-Madison have derived and cultured human embryonic stem cells, opening doors to growing tissues from scratch. The achievement has profound implications for transplant medicine and drug discovery, offering new possibilities for treating diseases such as Parkinson's and heart disease.
Scientists found that adult mouse blood stem cells can survive in the early embryo and produce blood cells with embryonic features, highlighting unexpected plasticity in blood cell programming. The study challenges accepted ideas on blood cell development and opens new avenues for understanding hematopoietic cell transplantations.